Capricor Therapeutics
CAPR
#7603
Rank
ยฃ0.38 B
Marketcap
ยฃ6.54
Share price
5.26%
Change (1 day)
47.22%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -ยฃ85.18 Million

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ77.95 Million a decrease over its 2024 earnings that were of -ยฃ30.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ85.18 Million9.28%
2025 -ยฃ77.95 Million159.57%
2024 -ยฃ30.03 Million81.57%
2023 -ยฃ16.54 Million-23.2%
2022 -ยฃ21.54 Million44.93%
2021 -ยฃ14.86 Million46.61%
2020 -ยฃ10.14 Million78.71%
2019 -ยฃ5.68 Million-49.7%
2018 -ยฃ11.28 Million-724.78%
2017 ยฃ1.8 M-112.93%
2016 -ยฃ13.96 Million46.27%
2015 -ยฃ9.55 Million106.82%
2014 -ยฃ4.62 Million-48.41%
2013 -ยฃ8.95 Million977.23%
2012 -ยฃ0.84 Million-77.11%
2011 -ยฃ3.63 Million-22.35%
2010 -ยฃ4.67 Million-20.17%
2009 -ยฃ5.85 Million-41.17%
2008 -ยฃ9.95 Million41.05%
2007 -ยฃ7.05 Million1098.87%
2006 -ยฃ0.59 Million4101.55%
2005 -ยฃ0.02 Million-0.97%
2004 -ยฃ0.02 Million17.87%
2003 -ยฃ0.02 Million3.66%
2002 -ยฃ0.02 Million-30.11%
2001 -ยฃ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.27 B-22,770.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.59 B-797.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-ยฃ0.62 Billion 623.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.23 Billion 169.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ4.64 Million-94.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ11.07 Million-86.98%๐Ÿ‡บ๐Ÿ‡ธ USA